Panel recommends a return for Multiple Sclerosis drug Tysabri

... WASHINGTON – A multiple sclerosis drug that was withdrawn from the market because of a life threatening side-effect last year is all set to return to the market following the recommendation of a federal advisory panel that the drug be put back on shelves. The panel unanimously recommended to the US Food and Drug Administration that Tysabri be allowed to return to the market. ...